EGFR and non-small cell lung carcinoma: Since there are no early diagnostic indicators for NSCLC, most patients are found in advanced stage without surgery potential, therefore, EGFR-TKIs were used for those patients with beneficial effect but some patients still had a poor prognosis rate (86–88).